This inventor holds 4 USPTO granted patents. Top assignees: Ball State University, Warner-Lambert Company, Other. Active years: 1996-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Indianapolis, IN (US) (1996 - 1997)
- Ann Arbor, MI (US) (1998 - 2002)
Company Filing History:
2 out of 8 
1 out of 2,538 
1 out of 834,570 Years Active: 1996-2002
Title: Ronald Lynn Merriman: Innovator in Cancer Treatment
Introduction
Ronald Lynn Merriman, based in Ann Arbor, MI, is an esteemed inventor with a focus on advancements in cancer treatment. With a total of four patents to his name, Merriman's work has contributed significantly to the field of oncology. His innovative approaches integrate chemistry and medicine, aiming to enhance therapeutic options for cancer patients.
Latest Patents
Merriman's latest patents showcase his commitment to developing effective cancer treatments. One of his notable inventions is related to the chemotherapy of cancer using acetyldinaline in combination with gemcitabine, capecitabine, or cisplatin. This synergistic approach has shown promise in improving treatment outcomes for cancer patients. His other recent patent involves quinoline-5,8-diones, which not only presents a novel chemical formula but also offers methods for utilizing them as potential antitumor agents. The antitumor activity of these compounds positions them as valuable tools in the fight against cancer.
Career Highlights
Throughout his career, Merriman has collaborated with reputable institutions and companies, helping to shape his research and innovations. Notably, he has been associated with Ball State University, where he contributed to academic advancements in the sciences. Additionally, he worked with Warner-Lambert Company, engaging in pharmaceutical innovations that have had lasting impacts on cancer treatments.
Collaborations
Ronald Lynn Merriman has worked alongside other prominent figures in the field, including Mohammad Behforouz and William Richard Grove. These collaborations have led to the sharing of knowledge and expertise, fostering an environment of innovation that benefits the broader medical community.
Conclusion
Ronald Lynn Merriman stands out as a significant inventor within the realm of cancer treatment. His groundbreaking patents and collaborative efforts highlight his dedication to improving the lives of individuals affected by cancer. As the landscape of oncology continues to evolve, Merriman's contributions will likely play a vital role in future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile